Results of randomized, multicenter, double-blind phase Ⅲ trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients by WANG, Jinwan, SUN, Yan, LIU, Yongyu, YU, Qitao, ZHANG, Yiping, LI, Kai, ZHU, Yunzhong, ZHOU, Qinghua, HOU, Mei, GUAN, Zhongzhen, LI, Weilian, Wu, ZHUANG, WANG, Donglin, LIANG, Houjie, QIN, Fengzhan, LU, Huishan, LIU, Xiaoqing, SUN, Hong, ZHANG, Yanjun, WANG, Jiejun, LUO, Suxia, YANG, Ruihe, TU, Yuanrong, WANG, Xiuwen, SONG, Shuping, ZHOU, Jingmin, YOU, Lifen, WANG, Jing, Chen, YAO

Get full text

Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients by Wang, Jinwan, Sun, Yan, Liu, Yongyu, Yu, Qitao, Zhang, Yiping, Li, Kai, Zhu, Yunzhong, Zhou, Qinghua, Hou, Mei, Guan, Zhongzhen, Li, Weilian, Zhuang, Wu, Wang, Donglin, Liang, Houjie, Qin, Fengzhan, Lu, Huishan, Liu, Xiaoqing, Sun, Hong, Zhang, Yanjun, Wang, Jiejun, Luo, Suxia, Yang, Ruihe, Tu, Yuanrong, Wang, Xiuwen, Song, Shuping, Zhou, Jingmin, You, Lifen, Wang, Jing, Yao, Chen

Get full text

A multicenter randomized phase III trial of domestic product of rmhTNF in the treatment of non-small cell lung cancer by Zhou, Qinghua, Yan, Xi, Ren, Li, Li, Lu, Qiu, Meng, Yang, Yuqiong, Luo, Deyun, Huang, Wenxia, Liu, Luming, Chen, Zhen, Meng, Zhiqiang, Wang, Yajie, Fu, Qiang, Xu, Yang, Yang, Linjun, Li, Mingzhong, Li, Enxiao, Li, Yi, Yao, Yu, Zhang, Xiangfu, Liu, Xing, Lu, Huishan, Zhang, Maohong, Wang, Xiuwen, Yu, Xuejun, Qin, Fengzhan, Zheng, Rongsheng, Chen, Yuqing, Bi, Minghong

Get full text

A multicenter randomized phase Ⅲ trial of domestic product of rmhTNF in the treatment of non-small cell lung cancer by ZHOU, Qinghua, YAN, Xi, Li, REN, Lu, LI, QIU, Meng, YANG, Yuqiong, LUO, Deyun, HUANG, Wenxia, LIU, Luming, CHEN, Zhen, MENG, Zhiqiang, WANG, Yajie, FU, Qiang, XU, Yang, YANG, Linjun, LI, Mingzhong, LI, Enxiao, LI, Yi, YAO, Yu, ZHANG, Xiangfu, LIU, Xing, LU, Huishan, ZHANG, Maohong, WANG, Xiuwen, YU, Xuejun, QIN, Fengzhan, ZHENG, Rongsheng, CHEN, Yuqing, Minghong, B I

Get full text

Phase Ⅲ Clinical Trials of the Cell Differentiation Agent-2 （CDA-2）： Therapeutic Efficacy on Breast Cancer, Non-Small Cell Lung Cancer and Primary Hepatoma by Fengyi Feng Qing Lu Changquan Ling Yang Zhang Fengzhan Qin Huaqing Wang Wenxia Huang Shunchang Jiao Qiang Chen Mingzhong Li Yunzhong Zhu Meizhen Zhou Jun Ren Yetao Gao Jingpo Zhao Rongsheng Zheng Wenhua Zhao Zhiqiang Meng Fang Li Qizhong Zhang Dongli Zhao Liyan Xu Yongqiang Zhang Yanjun Zhang Zhenjiu Wang Shuonqi Liu Ming C. Liau

Get full text

Infiltrated Sr0.9Y0.1CoO2.5+δ nanoparticles as a cathode material for solid oxide fuel cells operated at 450–650 °C by Si, Fengzhan, Shao, Lin, Kang, Xiaomin, Qin, Changyong, Huang, Kevin, Fu, Xianzhu, Luo, Jingli

Get full text

Infiltrated Sr0.9Y0.1CoO2.5+δ nanoparticles as a cathode material for solid oxide fuel cells operated at 450–650 °C by Si, Fengzhan, Shao, Lin, Kang, Xiaomin, Qin, Changyong, Huang, Kevin, Fu, Xianzhu, Luo, Jingli

Get full text

AB179. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells by Hu, Fengzhan, Yuan, Wanqiong, Wang, Xiaolin, Sheng, Zhengzuo, Yuan, Yeqing, Qin, Caipeng, He, Chongjun, Xu, Tao

Get full text